Insider · CIK 0001782814
Nolet Chris
Reports to the SEC for 5 companies · NEWTOWN SQUARE, PA
Transactions
32
Companies
5
Filings
15
CIK
0001782814
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-18 | AVBPArriVent BioPharma, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2025-07-03 | JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2025-06-18 | AVBPArriVent BioPharma, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2025-02-06 | Revance Therapeutics, Inc.D Disposition to Issuer | — |
| 2025-02-04 | Revance Therapeutics, Inc.U Disposition from Tender | −$104K |
| 2024-06-06 | JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2024-05-01 | Revance Therapeutics, Inc.A Award | — |
| 2024-05-01 | Revance Therapeutics, Inc.Stock Option (Right to buy)A Award | — |
| 2024-01-25 | AVBPArriVent BioPharma, Inc. · Stock Option (right to buy)A Award | — |
| 2023-06-07 | JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2023-05-03 | Revance Therapeutics, Inc.A Award | — |
| 2023-05-03 | Revance Therapeutics, Inc.Stock Option (Right to buy)A Award | — |
| 2023-01-12 | POLARITYTE, INC.M Exercise/Conversion | — |
| 2023-01-12 | POLARITYTE, INC.Stock option (right to buy)M Exercise/Conversion | — |
| 2022-10-12 | JSPRJasper Therapeutics, Inc.A Award | — |
| 2022-10-01 | POLARITYTE, INC.A Award | — |
| 2022-05-04 | Revance Therapeutics, Inc.A Award | — |
| 2022-05-04 | Revance Therapeutics, Inc.Stock Option (Right to buy)A Award | — |
| 2022-05-04 | Revance Therapeutics, Inc.Stock Option (Right to buy)A Award | — |
| 2022-03-21 | JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2021-05-05 | Revance Therapeutics, Inc.A Award | — |
| 2021-05-05 | Revance Therapeutics, Inc.Stock Option (Right to buy)A Award | — |
| 2021-03-15 | Viela Bio, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2021-03-15 | Viela Bio, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2021-01-01 | POLARITYTE, INC.Stock option (Right to Buy)A Award | +$79.9K |
| 2020-06-19 | Viela Bio, Inc.Stock Option (right to buy)A Award | — |
| 2020-05-14 | Revance Therapeutics, Inc.A Award | — |
| 2020-05-14 | Revance Therapeutics, Inc.Stock Option (Right to buy)A Award | — |
| 2020-04-06 | POLARITYTE, INC.Stock Option (right to buy)A Award | — |
| 2019-10-02 | Viela Bio, Inc.Stock Option (right to buy)A Award | — |
| 2019-07-16 | Revance Therapeutics, Inc.A Award | — |
| 2019-07-16 | Revance Therapeutics, Inc.Stock Option (Right to buy)A Award | — |
Recent filings
- 4Nolet Chris0001104659-26-076566SEC(opens sec.gov)
- 4Nolet Chris0001213900-25-061498SEC(opens sec.gov)
- 4Nolet Chris0001104659-25-061267SEC(opens sec.gov)
- 4Nolet Chris0000950170-25-015339SEC(opens sec.gov)
- 4Nolet Chris0001213900-24-051414SEC(opens sec.gov)
- 4Nolet Chris0001479290-24-000088SEC(opens sec.gov)
- 4Nolet Chris0001104659-24-007733SEC(opens sec.gov)
- 4Nolet Chris0001213900-23-047569SEC(opens sec.gov)
- 4Nolet Chris0001479290-23-000062SEC(opens sec.gov)
- 4Nolet Chris0001493152-23-001628SEC(opens sec.gov)
- 4Nolet Chris0001213900-22-063938SEC(opens sec.gov)
- 4Nolet Chris0001493152-22-027578SEC(opens sec.gov)
- 4/ANolet Chris0001479290-22-000067SEC(opens sec.gov)
- 4Nolet Chris0001479290-22-000063SEC(opens sec.gov)
- 4Nolet Chris0001213900-22-014564SEC(opens sec.gov)
Companies
Address
C/O ARRIVENT BIOPHARMA, INC. 18 CAMPUS BOULEVARD SUITE 100
NEWTOWN SQUARE, PA, 19073